Stocks

GeneDx Holdings WGS

Health care sectorNasdaq

What to see in GeneDx Holdings now

Is Wall Street adding or cutting?−17

223 13F filers hold it · −17 against the quarter before · shares held +2.0%

Holdings of 06/30
Who bought more than 5%?5.8%

Goldman Sachs Group holds 5.8% · +1.9pp on the report before

Filed 08/11
Is stock about to come to market?$1.7M

$1.7M of planned sales filed in 30 days · 0.1% of the units outstanding

Filed 09/01

Company

Exchange
Nasdaq
Industry
Services-Health Services
Headquarters
Stamford, Connecticut
Fiscal year end
12/31
Next earnings
10/18, estimated
  • 223 13F filers hold it · −17 against the quarter before · shares held +2.0%Holdings of 06/30
  • Goldman Sachs Group holds 5.8% · +1.9pp on the report beforeFiled 08/11

Funds

13F filers: 223 · −17 since the quarter before · 06/30 holdings

Famous funds that held GeneDx Holdings in their latest 13F report.

FundValueSince the quarter before
ARK Investment ManagementGeneDx Holdings WGS · 06/30 holdings$110.5MAdded +21.6%
Mirae Asset Global ETFS HoldingsGeneDx Holdings WGS · 06/30 holdings$2.5MNo quarter before
All tracked funds

5% stakes

Holder
Goldman Sachs Group08/115.8%1,733,592.38 sh+1.9pp
BlackRock07/285.5%1,622,518 shFirst report
CMLS Holdings05/2217.9%5,356,767 sh+0.0pp
CMLS Holdings05/1517.9%5,356,767 sh+1.2pp
CMLS Holdings05/1116.7%5,005,494 sh+4.2pp
William Blair Investment Management25/11/124.3%1,235,681 sh−1.4pp
CMLS Holdings25/08/2612.5%3,630,826 sh−1.7pp
Summit Partners Public Asset Management25/08/143.04%867,265 sh−2.1pp
FMR25/08/060.6%163,323.86 sh−9.4pp
William Blair Investment Management25/07/305.7%1,631,402 shFirst report
FMR25/05/1210%2,793,952.77 shFirst report
Goldman Sachs Group25/05/093.9%1,106,751.61 sh−1.3pp
CMLS Holdings25/05/0714.2%4,096,095 shNo earlier report
School Of Medicine At Mount Sinai Icahn25/02/214.89%1,373,569 sh−1.2pp
School Of Medicine At Mount Sinai Icahn25/02/186.1%1,680,016 shNo earlier report
Summit Partners Public Asset Management25/02/125.19%1,426,968 shFirst report
Goldman Sachs Group25/02/055.2%1,421,903 shFirst report
All 5% stake reports on GeneDx Holdings

26-week trading